close
close

Walgreens Boots Alliance, Inc. (WBA) study:

Walgreens Boots Alliance, Inc. (WBA) study:

NEW YORK, July 9, 2024 (GLOBE NEWSWIRE) — Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. (“Walgreens Boots” or “the Company”) (NASDAQ: WBA). Investors who purchased securities of Walgreens Boots are encouraged to obtain additional information and assist the investigation by visiting the Company’s website: bgandg.com/WBA.

Examination details

On June 27, 2024, Walgreens reported its third-quarter 2024 earnings. According to The Motley Fool, “The big change was that full-year earnings guidance was cut to $2.80 to $2.95 per share from $3.20 to $3.35. This is the second time this year the company has cut its guidance. Management said it will close some unprofitable stores and scale back some products that it believes have too low margins.” Following this news, Walgreens shares fell over 22% the same day.

What’s next?

If you are aware of facts related to this investigation, or if you purchased securities of Walgreens Boots, you can assist this investigation by visiting the company’s website: bgandg.com/WBA. You may also contact Peretz Bronstein or his account representative Nathan Miller of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There are no costs for you

We represent investors in class action lawsuits on a contingency basis, meaning we ask the court to reimburse us for our expenses and attorney fees (usually a percentage of the total award) only if we win.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized law firm representing investors in securities fraud class action lawsuits and shareholder actions involving derivatives trading. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Past results do not guarantee similar results.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | [email protected]